Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 4Ovarian Neoplasms 3Colorectal Neoplasms 3Thyroid Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoma 2Hematologic Neoplasms 2Glioma 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Neurofibromatosis 1 1Lymphatic Metastasis 1Lung Neoplasms 1Klatskin Tumor 1Hereditary Sensory and Autonomic Neuropathies 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1

Interventions

durvalumab 7Gemcitabine 7Oxaliplatin 6Magnetic Resonance Spectroscopy 6Leucovorin 6Cisplatin 6Specimen Handling 5Fluorouracil 5Biopsy 5Paclitaxel 4Folfox protocol 4Irinotecan 3pemigatinib 2pembrolizumab 2olaparib 2futibatinib 2fludarabine 2dehydroftorafur 2Taxes 2Nivolumab 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Disulfides 2Carboplatin 2zimberelimab 1zanidatamab 1ulixertinib 1tremelimumab 1trametinib 1tocilizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cholangiocarcinoma × binimetinib × 30 days × Clear all
NCT05564403 2026-05-13

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
66 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡